341 related articles for article (PubMed ID: 27225425)
1. MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy.
Wang Y; Yan H
Sci Rep; 2016 May; 6():26909. PubMed ID: 27225425
[TBL] [Abstract][Full Text] [Related]
2. Niaspan inhibits diabetic retinopathy‑induced vascular inflammation by downregulating the tumor necrosis factor‑α pathway.
Wang Y; Meng X; Yan H
Mol Med Rep; 2017 Mar; 15(3):1263-1271. PubMed ID: 28138697
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
5. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
6. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy.
Zhang C; Nie J; Feng L; Luo W; Yao J; Wang F; Wang H
Discov Med; 2016 Apr; 21(116):227-37. PubMed ID: 27232509
[TBL] [Abstract][Full Text] [Related]
7. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
[TBL] [Abstract][Full Text] [Related]
8. TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.
Jiang F; Chen Q; Huang L; Wang Y; Zhang Z; Meng X; Liu Y; Mao C; Zheng F; Zhang J; Yan H
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120595
[TBL] [Abstract][Full Text] [Related]
9. Effects of microRNA-133b on retinal vascular endothelial cell proliferation and apoptosis through angiotensinogen-mediated angiotensin II- extracellular signal-regulated kinase 1/2 signalling pathway in rats with diabetic retinopathy.
Liu TT; Hao Q; Zhang Y; Li ZH; Cui ZH; Yang W
Acta Ophthalmol; 2018 Aug; 96(5):e626-e635. PubMed ID: 29488353
[TBL] [Abstract][Full Text] [Related]
10. Dendrobium chrysotoxum Lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease.
Yu Z; Gong C; Lu B; Yang L; Sheng Y; Ji L; Wang Z
J Diabetes Res; 2015; 2015():518317. PubMed ID: 25685822
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
13. The ethanol extract of Zingiber zerumbet rhizomes mitigates vascular lesions in the diabetic retina.
Hong TY; Tzeng TF; Liou SS; Liu IM
Vascul Pharmacol; 2016 Jan; 76():18-27. PubMed ID: 26319672
[TBL] [Abstract][Full Text] [Related]
14. δ Opioid Receptor Agonism Preserves the Retinal Pigmented Epithelial Cell Tight Junctions and Ameliorates the Retinopathy in Experimental Diabetes.
Lopes de Faria JM; Duarte DA; Simó R; García-Ramirez M; Dátilo MN; Pasqualetto FC; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3842-3853. PubMed ID: 31529081
[TBL] [Abstract][Full Text] [Related]
15. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.
Leal EC; Martins J; Voabil P; Liberal J; Chiavaroli C; Bauer J; Cunha-Vaz J; Ambrósio AF
Diabetes; 2010 Oct; 59(10):2637-45. PubMed ID: 20627932
[TBL] [Abstract][Full Text] [Related]
16. Luo Tong Formula Alleviates Diabetic Retinopathy in Rats Through Micro-200b Target.
Pang B; Ni Q; Di S; Du LJ; Qin YL; Li QW; Li M; Tong XL
Front Pharmacol; 2020; 11():551766. PubMed ID: 33324202
[No Abstract] [Full Text] [Related]
17. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
[TBL] [Abstract][Full Text] [Related]
18. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model.
Shin JY; Sohn J; Park KH
J Korean Med Sci; 2013 Apr; 28(4):608-13. PubMed ID: 23579598
[TBL] [Abstract][Full Text] [Related]
19. Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy.
Wang Q; Navitskaya S; Chakravarthy H; Huang C; Kady N; Lydic TA; Chen YE; Yin KJ; Powell FL; Martin PM; Grant MB; Busik JV
EBioMedicine; 2016 Sep; 11():138-150. PubMed ID: 27531575
[TBL] [Abstract][Full Text] [Related]
20. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
